A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, Ph.D., researcher at Huntsman Cancer Institute (HCI) and assistant professor of oncological sciences at the University of Utah.
Source: EurekaAlert, https://www.eurekalert.org